These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38048980)

  • 1. Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement.
    Šoštarić P; Matić M; Nemanić D; Lučev Vasić Ž; Cifrek M; Pirazzini M; Matak I
    Eur J Pharmacol; 2024 Jan; 962():176242. PubMed ID: 38048980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for central antispastic effect of botulinum toxin type A.
    Matak I
    Br J Pharmacol; 2020 Jan; 177(1):65-76. PubMed ID: 31444910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasting Peripheral and Central Effects of Botulinum Toxin Type A on Experimental Muscle Hypertonia in Rats.
    Šoštarić P; Vukić B; Tomašić L; Matak I
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
    Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
    PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological effects of botulinum toxin type A.
    Abbruzzese G; Berardelli A
    Neurotox Res; 2006 Apr; 9(2-3):109-14. PubMed ID: 16785106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
    Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
    J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
    Mazzocchio R; Caleo M
    Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis.
    Nemanić D; Mustapić M; Matak I; Bach-Rojecky L
    Eur J Pharmacol; 2024 Jan; 963():176279. PubMed ID: 38123005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
    Cai BB; Francis J; Brin MF; Broide RS
    Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
    Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
    Marinelli S; Vacca V; Ricordy R; Uggenti C; Tata AM; Luvisetto S; Pavone F
    PLoS One; 2012; 7(10):e47977. PubMed ID: 23110146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.
    Smith CP; Gangitano DA; Munoz A; Salas NA; Boone TB; Aoki KR; Francis J; Somogyi GT
    Neurochem Int; 2008 May; 52(6):1068-75. PubMed ID: 18187233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism.
    Raghunath A; Perez-Branguli F; Smith L; Dolly JO
    J Neurosci; 2008 Apr; 28(14):3683-8. PubMed ID: 18385326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basis of movement control in dystonia and why botulinum toxin should influence it?
    Wagle Shukla A
    Toxicon; 2024 Jan; 237():107251. PubMed ID: 37574115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.
    Hull M; Anupindi VR; DeKoven M; He J; Bouchard J
    Adv Ther; 2023 Sep; 40(9):3986-4003. PubMed ID: 37414904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Central Effects of Botulinum Toxin in Dystonia and Spasticity.
    Hok P; Veverka T; Hluštík P; Nevrlý M; Kaňovský P
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
    Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.